These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19213074)

  • 1. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
    Johnson TW; Kay IP; Ormiston JA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent.
    Ormiston JA; Lefèvre T; Grube E; Allocco DJ; Dawkins KD
    EuroIntervention; 2010 May; 6(1):46-53. PubMed ID: 20542797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for a dedicated bifurcation stenting system.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):641-2. PubMed ID: 19309702
    [No Abstract]   [Full Text] [Related]  

  • 4. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience.
    Burzotta F; Gwon HC; Hahn JY; Romagnoli E; Choi JH; Trani C; Colombo A
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):75-82. PubMed ID: 17585382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflation time and drug-eluting stent: the longer, the better..
    Bertrand OF
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion.
    Kawasaki T; Koga H; Serikawa T; Orita Y; Ikeda S; Mito T; Gotou Y; Shintani Y; Tanaka A; Tanaka H; Fukuyama T; Koga N
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):205-11. PubMed ID: 19085915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioabsorbable drug-eluting stents: the future of coronary angioplasty?
    Macaya C; Moreno R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):598-9. PubMed ID: 18679382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery aneurysm formation after drug-eluting stent implantation.
    Levisay JP; Roth RM; Schatz RA
    Cardiovasc Revasc Med; 2008; 9(4):284-7. PubMed ID: 18928957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-label use and the spectre of drug-eluting stent thrombosis.
    Cook S; Wenaweser P
    Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
    [No Abstract]   [Full Text] [Related]  

  • 13. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment with optical coherence tomography of a new strategy for bifurcational lesion treatment: the Tryton Side-Branch Stent.
    Ferrante G; Kaplan AV; Di Mario C
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):69-72. PubMed ID: 19089962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 16. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
    Bailey SR
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of ostial lesions using the Szabo technique: a case series.
    Applegate RJ; Davis JM; Leonard JC
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):823-8. PubMed ID: 18798240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Petal dedicated bifurcation stent.
    Ormiston JA; De Vroey F; Webster MW; Kandzari DE
    EuroIntervention; 2010 Dec; 6 Suppl J():J139-42. PubMed ID: 21930479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.